Bio-ADM as a Biomarker of Refilling in Chronic Hemodialysis Patient (REFILBIOADM)

University Hospital Center (CHU)

Status: Unknown

Conditions: Chronic Kidney Disease 5D

Treatments: Biological: BioADM determination in plasma

Study type: Observational

Funder types: Other

Identifiers

NCT05339009

RECHMPL21_0068

Details and patient eligibility

About

Aim of this study is to evaluate in a population of chronic kidney disease patients on dialysis (Stage 5D) the predictive value of bio-adrenomedullin (bio-ADM) level on vascular refilling rate.

Enrollment: 150 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Chronic Kidney Disease patient on dialysis (stage 5D) for more than 1 month
• Anuric patient

Exclusion criteria

• Patient protected by law
• Patient under guardianship ou curatorship
• Patient deprived of liberty

Trial design

150 participants in 1 patient group

All patients receive conventional dialysis treatment at inclusion

Description:

All patients receive conventional dialysis treatment at inclusion

Treatment:

Biological: BioADM determination in plasma